20 авг. 2024 г. · EQT Life Sciences is pleased to announce that its portfolio company Endotronix has been acquired by Edwards Lifesciences.

Patient management platform for early detection of worsening heart failure. Sector: Healthcare. Country: United States. Fund: LSP HEF 2 Entry 2018.

14 сент. 2018 г. · For suitable patients, the system seamlessly integrates pulmonary artery pressure data with a next generation wireless, implantable sensor.

ENDOTRONIX IS AN EDWARDS LIFESCIENCES COMPANY. Empowering proactive heart failure management in the home. Successful management for congested heart failure (HF) ... Endotronix Strengthens... · Endotronix Announces... · Endotronix Receives FDA... Не найдено: eqt | Нужно включить: eqt

Endotronix is developing data-driven solutions to advance the treatment of heart failure. Learn more about Endotronix and its management team.

EQT Life Sciences EQT Life Science develops novel medications, devices, and tools to address people's health concerns.

25 июл. 2024 г. · Heart failure tech developer Endotronix is being acquired by Edwards Lifesciences a month after receiving regulatory approval for its ...

28 сент. 2024 г. · Endotronix, an Edwards Lifesciences company, innovates at the intersection of medtech and digital health to improve care for people living with ...

Endotronix has 16 institutional investors including Life Sciences Partners, SVB and EQT. View details of Endotronix funding rounds and investors. Endotronix's ...

14 окт. 2018 г. · Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management ...